1. Home
  2. BHVN vs MEOH Comparison

BHVN vs MEOH Comparison

Compare BHVN & MEOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • MEOH
  • Stock Information
  • Founded
  • BHVN 2013
  • MEOH 1968
  • Country
  • BHVN United States
  • MEOH Canada
  • Employees
  • BHVN N/A
  • MEOH N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • MEOH Major Chemicals
  • Sector
  • BHVN Health Care
  • MEOH Industrials
  • Exchange
  • BHVN Nasdaq
  • MEOH Nasdaq
  • Market Cap
  • BHVN 1.9B
  • MEOH 2.2B
  • IPO Year
  • BHVN 2017
  • MEOH N/A
  • Fundamental
  • Price
  • BHVN $14.63
  • MEOH $34.37
  • Analyst Decision
  • BHVN Strong Buy
  • MEOH Buy
  • Analyst Count
  • BHVN 14
  • MEOH 9
  • Target Price
  • BHVN $58.85
  • MEOH $46.89
  • AVG Volume (30 Days)
  • BHVN 2.0M
  • MEOH 815.8K
  • Earning Date
  • BHVN 08-07-2025
  • MEOH 07-29-2025
  • Dividend Yield
  • BHVN N/A
  • MEOH 2.15%
  • EPS Growth
  • BHVN N/A
  • MEOH 24.27
  • EPS
  • BHVN N/A
  • MEOH 3.06
  • Revenue
  • BHVN N/A
  • MEOH $3,700,592,000.00
  • Revenue This Year
  • BHVN $3.00
  • MEOH $10.01
  • Revenue Next Year
  • BHVN $59.97
  • MEOH $14.10
  • P/E Ratio
  • BHVN N/A
  • MEOH $11.98
  • Revenue Growth
  • BHVN N/A
  • MEOH 2.77
  • 52 Week Low
  • BHVN $13.87
  • MEOH $25.46
  • 52 Week High
  • BHVN $55.70
  • MEOH $54.49
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 41.97
  • MEOH 51.21
  • Support Level
  • BHVN $14.00
  • MEOH $32.66
  • Resistance Level
  • BHVN $15.09
  • MEOH $34.56
  • Average True Range (ATR)
  • BHVN 0.73
  • MEOH 1.33
  • MACD
  • BHVN 0.13
  • MEOH -0.20
  • Stochastic Oscillator
  • BHVN 41.44
  • MEOH 33.60

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About MEOH Methanex Corporation

Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through a global supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.

Share on Social Networks: